News

Numab, Boehringer Ingelheim collaborate to develop multi-specific antibody therapeutics for cancer

The T-cell engager to be developed with Numab adds to Boehringer Ingelheim’s growing cancer immunology portfolio.

Read More

Jul 09, 2020

By : Team ABLE

NIH launches clinical trials network to test COVID-19 vaccines and other prevention tools

The network has developed an extensive community engagement framework to reach out to potential research volunteers

Read More

Jul 09, 2020

By : Team ABLE

ABLE Member Praj announces major Renewable Chemicals and Materials (RCM) portfolio with Bio-Prism product launch

As a part of its newly launched Bio-Prism portfolio, Praj is developing technologies to produce bio-based Renewable Chemicals and Materials (RCM).

Read More

Jul 09, 2020

By : Team ABLE

The European Molecular Biology Organisation extends lifetime membership to NCBS scientist Sumantra Chattarji

It is believed that EMBO bestows lifetime membership to only a few selected scientists across the world who have done outstanding work in their respective fields.

Read More

Jul 09, 2020

By : Team ABLE

European Investment Bank and CureVac sign €75 million loan agreement for development of vaccine candidate against SARS-CoV-2

CureVac’s mRNA technology platform has believed to have shown potential in the clinical development and production of mRNA based vaccines and therapeutics.

Read More

Jul 09, 2020

By : Team ABLE

 

BioEconomy Conclave 2026

24th February | TAJ MG Road, Bengaluru

Exhibit in the 'India Pavilion' at BIO 2026

June 22-25 | San Diego, USA

Focus Areas

Highlights